HQY logo

HEALTHEQUITY INC

HQYNASDAQ
πŸ† #853 by market capEarnings Aug 27US Equity
$104.44β–Ό $1.12 (βˆ’1.07%)
Live
1hβ€”
24hβ–Ό 1.1%
7dβ–² 0.0%
14dβ–² 0.3%
30dβ–² 9.2%
1yβ–² 12.3%
🏦Market Cap
$8.73B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+9.5%
Slowing
πŸ“ŠGross Margin
72.7%
High
πŸ’΅FCF Margin
36.5%
Strong
βš–οΈP/S Ratio
6.5x
Fair
Otter Score
60
Fair

Trading Snapshot

Day Range
$103.98 – $105.37
52-Week Range
$72.76 – $107.62
Volume
$3.55B
Avg Volume
$3.26B
Shares Outstanding
83.6M
Next Earnings
Sep 9, 2026

Fundamentals Snapshot

Annual Revenue
$1.31B
Last Q Revenue
$355M
P/E Ratio
38.7
P/S Ratio
6.5x
EPS (TTM)
$2.73
Dividend Yield
0.00%

Why Investors Own HQY

  • βœ“High-growth profile β€” revenue up +49.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 73% gross margin and 18% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1.31Bβ–² +43.9% YoY
Gross Margin (TTM)
72.8%β–Ό βˆ’0.5% YoY
Operating Income (TTM)
$120Mβ–² +43.9% YoY
Free Cash Flow (TTM)
$238Mβ–² +43.9% YoY

About HEALTHEQUITY INC

Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow their savings through various investment avenues, including specific investment choices. In addition to these personal financial management tools, HealthEquity administers a range of health-related accounts, such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Its offerings also encompass a mutual fund investment platform, an automated online advisory service known as Advisor, COBRA continuation services, and the management of pre-tax commuter benefits programs. HealthEquity markets its services through a dedicated direct sales team, collaborates with benefits brokers and advisors, and leverages a comprehensive network comprising health plans, benefits administrators, consultants, and retirement plan record-keepers.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
60/100

Analyst Ratings

β“˜
Consensus
Buy
20 analysts
Strong Buy7
Buy12
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates

YahooΒ·5d ago

Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates

Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of +29.03% and -0.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

YahooΒ·6d ago

GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates

GoodRx (GDRX) delivered earnings and revenue surprises of 0.00% and +3.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

YahooΒ·8d ago

HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule

DRAPER, Utah, Aug. 03, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (β€œHealthEquity” or the β€œCompany”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced plans to release financial results for its second quarter of fiscal 2027, before the opening of regular stock market trading on Thursday, August 27, 2026. Following the news release, HealthEquity management will host a conference call fo

YahooΒ·8d ago

HealthEquity (HQY) Upgraded to Buy: What Does It Mean for the Stock?

HealthEquity (HQY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SeekingAlphaΒ·16d ago

HealthEquity's Earnings Momentum Deserves More Credit

HealthEquity is the leading HSA and CDB administrator, consistently beating revenue and EPS expectations with strong operational execution. More on HQY stock.

🌌
BenzingaΒ·19d ago

BTIG Maintains Buy on HealthEquity, Raises Price Target to $115

BTIG analyst David Larsen maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $110 to $115.